Atrial Fibrillation and Heart Failure in Women

Nidhi Madan1, Dipti Itchhaporia2, Christine M Albert3

  • 1Department of Medicine, Cardiology Division, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA.

Heart Failure Clinics
|November 20, 2018
PubMed

Insights

Atrial fibrillation and heart failure together worsen outcomes, especially in women. Understanding sex differences in atrial fibrillation and heart failure is crucial for improving treatments and patient survival.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Sex Differences in Health

Background:

  • Atrial fibrillation (AF) and heart failure (HF) frequently coexist, often exacerbating each other.
  • The combined presence of AF and HF is associated with poorer clinical outcomes compared to either condition alone.
  • Significant sex-based disparities exist in the incidence, prevalence, pathophysiology, treatment, and outcomes of patients with AF and HF.

Purpose of the Study:

  • To explore the critical sex differences in atrial fibrillation and heart failure.
  • To emphasize the importance of risk stratification in these patient populations.
  • To highlight current treatment strategies and identify areas for improvement to enhance clinical outcomes, particularly for women.

Main Methods:

  • This study is a comprehensive literature review.
  • It synthesizes existing research on sex differences in AF and HF.
  • Focuses on risk factors, disease mechanisms, and therapeutic interventions.

Main Results:

  • Women with HF have a higher risk of developing AF than men.
  • Women with AF are more likely to develop HF.
  • Women experience higher mortality rates from AF-related strokes, and current treatments remain inadequate for them.

Conclusions:

  • Sex-related differences significantly impact the interplay between atrial fibrillation and heart failure.
  • Women face a disproportionately higher burden of morbidity and mortality.
  • Improved risk stratification and tailored treatments are essential to address these sex-specific challenges and improve outcomes.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971